BSE Live
Jan 20, 13:02Prev. Close
453.20
Open Price
453.00
Today’s L/H
52 Wk L/H
L/U Price Band
Bid Price (Qty.)
435.00 (11)
Offer Price (Qty.)
440.00 (15)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 11 | 435.00 | 440.00 | 15 |
| 1 | 430.65 | 445.90 | 15 |
| 1 | 430.50 | 445.95 | 2 |
| 25 | 430.10 | 446.00 | 10 |
| 13 | 430.05 | 447.95 | 1 |
| 2360 | Total | Total | 3150 |
NSE Live
Prev. Close
Open Price
Today’s L/H
52 Wk L/H
L/U Price Band
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 457.23 | 461.27 | 469.33 | 449.17 | 445.13 | 437.07 | 433.03 |
| Fibonacci | 453.79 | 456.64 | 461.27 | 449.17 | 444.54 | 441.69 | 437.07 |
| Camarilla | 454.31 | 455.42 | 456.53 | 449.17 | 452.09 | 450.98 | 449.87 |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | BSE |
|---|---|
| 5 | 442.35 |
| 10 | 447.38 |
| 20 | 423.54 |
| 50 | 415.48 |
| 100 | 423.34 |
| 200 | 459.80 |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.
* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quart...  View more
Posted by : BSE/NSE Announcer
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quart...  View more
Posted by : BSE/NSE Announcer
Jenburkt Pharma AGM on Jul 30, 2019, Announcement date: May 28, 2019
Jul 29, 11:00
Jenburkt Pharma closes above 50-Day Moving Average of 495.02 today.
May 07
Jenburkt Pharma AGM on Jul 31, 2018, Announcement date: May 30, 2018
Jul 30, 11:00
Jenburkt Pharma Dividend, Interim Dividend 30.00%, Announcement date: Mar 16, 2018, Record date: Mar 28, 2018, Ex-Div: Mar 27, 2018
Mar 26, 11:00
Jenburkt Pharma: A steady performer in the smallcap space
Dec 11, 15:30
Jenburkt Pharma POM on Oct 27, 2017, Announcement date: Sep 27, 2017
Oct 26, 11:00
Jenburkt Pharma approves buyback of equity shares
Sep 11, 08:30
Jenburkt Pharma's board meeting held on August 29, 2017
Aug 22, 08:00
Jenburkt Pharma: Outcome of AGM
Aug 01, 15:30
Jenburkt Pharma AGM on Jul 31, 2017, Announcement date: May 31, 2017
Jul 30, 11:00
Only Buyers in Jenburkt Pharma on BSE
May 31, 10:05
Only Sellers in Jenburkt Pharma on BSE
Feb 21, 11:20
Only Buyers in Jenburkt Pharma on BSE
Oct 24, 10:05
Jenburkt Pharma AGM on Jul 27, 2016, Announcement date: May 31, 2016
Jul 26, 11:01
Jenburkt Pharmaceuticals to consider dividend
May 19, 13:29
Jenburkt Pharma Dividend, Interim Dividend 63.00%, Announcement date: Mar 08, 2016, Record date: Mar 18, 2016, Ex-Div: Mar 17, 2016
Mar 16, 10:59
Jenburkt Pharmaceuticals declares interim dividend
Mar 10, 15:31
Buy Jenburkt Pharma; target of Rs 520: Firstcall
Jan 06, 09:52
Jenburkt Pharmaceuticals: Updates of outcome of AGM
Sep 29, 08:16
Jenburkt Pharma AGM on Sep 08, 2015, Announcement date: Jul 27, 2015
Sep 07, 11:18
04:35 PM Jan 07, 2020
Jenburkt Pharma - Shareholding for the Period Ended December 31, 2019
12:11 PM Jan 07, 2020
Jenburkt Pharma - Statement Of Investor Complaints For The Quarter Ended December 2019 (Revised)
12:10 PM Jan 07, 2020
Jenburkt Pharma - Statement Of Investor Complaints For The Quarter Ended December 2019
11:15 AM Jan 02, 2020
11:18 AM Dec 31, 2019
Jenburkt Pharma - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
02:52 PM Dec 17, 2019
Jenburkt Pharma - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | |
|---|---|---|---|---|---|
| Net Sales | 34.18 | 20.84 | 35.13 | 32.28 | 31.98 |
| Other Income | 0.86 | 1.24 | 0.93 | 0.67 | 0.90 |
| PBDIT | 7.42 | -0.61 | 8.91 | 6.36 | 7.07 |
| Net Profit | 5.55 | 0.06 | 6.89 | 4.46 | 5.74 |
| Standalone | Mar 2019 | Mar 2018 |
|---|---|---|
| Total Share Capital | 4.59 | 4.59 |
| Networth | 77.47 | 61.26 |
| Total Debt | 7.47 | 0.24 |
| Net Block | 9.59 | 9.57 |
| Investments | 5.38 | 5.42 |
| Total Assets | 84.93 | 61.50 |
|
On
|
Current Price | %Gain / Loss | |
|---|---|---|---|
| Open Price | 543.00 | 453.00 | -16.57 |
| High Price | 543.00 | 453.00 | -16.57 |
| Low Price | 515.00 | 430.00 | -16.5 |
| Close Price | 525.40 | 453.20 | -13.74 |
| Volume | 4,984 | 1,258 | -74.76 |
|
On
|
Current Price | %Gain / Loss | |
|---|---|---|---|
| No Record Found | |||
| Index | Price | Change | %Chg |
|---|---|---|---|
| NIFTY 50 | 12264.80 | -87.60 | -0.71 |
| SENSEX | 41657.74 | -287.63 | -0.69 |
| NIFTY BANK | 31279.70 | -310.95 | -0.98 |
| NIFTY IT | 16203.80 | -152.80 | -0.93 |
| S&P BSE Smallcap | 14679.44 | -29.26 | -0.20 |
| Index | Price | Change | %Chg |
|---|---|---|---|
| Straits Times (Jan 20) | 3,276.33 | -4.70 | -0.14 |
| Shanghai Composite (Jan 20) | 3,095.79 | 20.29 | 0.66 |
| KOSPI (Jan 20) | 2,262.64 | 12.07 | 0.54 |
| Nikkei 225 (Jan 20) | 24,083.51 | 42.25 | 0.18 |
| SGX Nifty (Jan 20) | 12,281.50 | -101.00 | -0.82 |
| Date | Agenda |
|---|---|
| Nov 05, 2019 | Audited Results |
| Jul 30, 2019 | Quarterly Results |
| May 28, 2019 | Audited Results & Final Dividend |
| Feb 05, 2019 | Quarterly Results |
| Type | Dividend% | Ex-Dividend date |
|---|---|---|
| Final | 102.00 | Jul 22, 2019 |
| Final | 60.00 | Jul 23, 2018 |
| Interim | 30.00 | Mar 27, 2018 |
| Final | 81.00 | Jul 21, 2017 |
| Final | 9.00 | Jul 19, 2016 |
| Ratio | Announcement Date | Ex-Bonus |
|---|---|---|
| No Bonus Information is available for Jenburkt Pharma | ||
| Old FV | New FV | Ex-Split |
|---|---|---|
| No Splits Information is available for Jenburkt Pharma | ||
| Ratio | Premium | Ex-Bonus |
|---|---|---|
| No Rights Information is available for Jenburkt Pharma | ||
| Date | Agenda |
|---|---|
| Jul 30, 2019 | - |
| Jul 31, 2018 | - |
| - | Buy Back of Shares |
| Oct 27, 2017 | - |
| Jul 31, 2017 | - |
Dividend Summary
For the year ending March 2019 Jenburkt Pharma has declared an equity dividend of 102.00% amounting to Rs 10.2 per share.
The company has a good dividend track report and has consistently declared dividends for the last 5 years.
| Standalone | June 2019 | March 2019 | December 2018 | September 2018 | |
|---|---|---|---|---|---|
| Promoters | 45.6 | 45.6 | 45.6 | 45.6 | |
| Pledged | 0 | 0 | 0 | 0 | |
| FII/FPI | 2.22 | 2.22 | 2.11 | 1.7 | |
| Total DII | 8.27 | 7.95 | 7.99 | 7.88 | |
| Fin.Insts | 0 | 0 | 0 | 0 | |
| Insurance Co | 0 | 0 | 0 | 0 | |
| MF | 0 | 0 | 0 | 0 | |
| Others DIIs | 8.27 | 7.95 | 7.99 | 7.88 | |
| Others | 43.91 | 44.23 | 44.29 | 44.82 | |
| Total | 100 | 100 | 99.99 | 100 |
| Company Name | Last Price | % Change | 52 Wk High | 52 Wk Low | Market Cap | Sales Qtr | Net Profit Qtr |
|---|---|---|---|---|---|---|---|
| Jenburkt Pharma | 435.00 | -4.02 | 560.00 | 380.15 | 199.64 | 122.64 | 19.80 |
| Sun Pharma | 449.10 | -1.18 | 484.10 | 350.40 | 107754.13 | 10,303.21 | 816.60 |
| Dr Reddys Labs | 3056.35 | 0.75 | 3067.70 | 2065.30 | 50784.72 | 10,625.50 | 1,277.30 |
| Divis Labs | 1912.90 | 0.50 | 1925.25 | 1460.55 | 50781.48 | 4,879.66 | 1,332.65 |
| Cipla | 480.00 | -0.05 | 585.50 | 389.55 | 38698.92 | 12,374.01 | 1,888.41 |
Jenburkt Pharma is in the Pharmaceuticals sector.
It is listed on the BSE with a BSE Code of 524731.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
